dc.contributorZanella, Renato
dc.contributorhttp://lattes.cnpq.br/2541865299438479
dc.contributorAdaime, Martha Bohrer
dc.contributorCabrera, Liziara da Costa
dc.contributorKemmerich, Magali
dc.contributorDonato, Filipe Fagan
dc.contributorPrestes, Osmar Damian
dc.creatorSchwaickhardt, Rômulo de Oliveira
dc.date.accessioned2022-05-27T16:45:55Z
dc.date.accessioned2022-10-07T22:38:44Z
dc.date.available2022-05-27T16:45:55Z
dc.date.available2022-10-07T22:38:44Z
dc.date.created2022-05-27T16:45:55Z
dc.date.issued2021-12-18
dc.identifierhttp://repositorio.ufsm.br/handle/1/24539
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/4037861
dc.description.abstractThe growth in production and consequently in the use of pharmaceuticals and personal care products over the years has made domestic effluents generated both in large cities and in small cities loaded with these compounds, making it practically impossible to find urban effluents free of these residues. This exponential increase was not followed by conventional effluent treatment plants. Thus, new treatment alternatives such as constructed wetlands emerge as a potential technology for removing these contaminants from effluents. Therefore, to evaluate the efficiency of this and other types of effluent treatment systems, it is necessary to develop multiclass methods to control the treatment. In this work, a multiclass method was developed for the analysis of 37 compounds among drugs in raw and treated effluent from wetlands constructed in different configurations. The determination was performed by ultra performance liquid chromatography coupled to mass spectrometry (UHPLC-MS/MS). The solid phase extraction method (SPE) was developed using Oasis HLB cartridge, the sample percolated at pH 5 and with 0.01 mol L-1 of EDTA was eluted with methanol and a subsequent step of cleaning the extract with PSA sorbent was added. (d-SPE). The method showed recoveries between 70 and 120%, precision and intermediate precision (RSD ≤ 20%). The limit of quantification (LQ) was between 0.025 and 0.100 μg L-1 and the detection limit between 0.008 and 0.030 μg L-1. The validated method was applied to evaluate the removal of drugs present in the effluent after passing through a system of wetlands built with 4 different treatment configurations. The 14 compounds found in the raw effluent, only 8 were still detected and in lower concentrations after the constructed wetlands system in best configuration.
dc.publisherUniversidade Federal de Santa Maria
dc.publisherBrasil
dc.publisherQuímica
dc.publisherUFSM
dc.publisherPrograma de Pós-Graduação em Química
dc.publisherCentro de Ciências Naturais e Exatas
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.subjectWetlands construídos
dc.subjectUHPLC-MS/MS
dc.subjectSPE
dc.subjectFármacos
dc.subjectEfluentes
dc.subjectConstructed wetlands
dc.subjectPharmaceuticals
dc.subjectWastewater
dc.titleDesenvolvimento e aplicação de método por UHPLC-MS/MS para determinação de fármacos em efluentes tratados em sistemas de wetlands construídos
dc.typeTese


Este ítem pertenece a la siguiente institución